Clowse, M. E. B., Scheuerle, A. E., Chambers, C. D., Afzali, A., Kimball, A., Cush, J. J., … Forger, F. (2017). Characteristics and Outcomes of Prospectively Reported Pregnancies Exposed to Certolizumab Pegol from a Safety Database. In ARTHRITIS & RHEUMATOLOGY (Vol. 69). WILEY.

Clowse, Megan E. B., Angela E. Scheuerle, Christina D. Chambers, Anita Afzali, Alexa Kimball, John J. Cush, Maureen Cooney, Laura Shaughnessy, Mark Vanderkelen, and Frauke Forger. “Characteristics and Outcomes of Prospectively Reported Pregnancies Exposed to Certolizumab Pegol from a Safety Database.” In ARTHRITIS & RHEUMATOLOGY, Vol. 69. WILEY, 2017.

Clowse MEB, Scheuerle AE, Chambers CD, Afzali A, Kimball A, Cush JJ, et al. Characteristics and Outcomes of Prospectively Reported Pregnancies Exposed to Certolizumab Pegol from a Safety Database. In: ARTHRITIS & RHEUMATOLOGY. WILEY; 2017.

Clowse, Megan E. B., et al. “Characteristics and Outcomes of Prospectively Reported Pregnancies Exposed to Certolizumab Pegol from a Safety Database.” ARTHRITIS & RHEUMATOLOGY, vol. 69, WILEY, 2017.

Clowse MEB, Scheuerle AE, Chambers CD, Afzali A, Kimball A, Cush JJ, Cooney M, Shaughnessy L, Vanderkelen M, Forger F. Characteristics and Outcomes of Prospectively Reported Pregnancies Exposed to Certolizumab Pegol from a Safety Database. ARTHRITIS & RHEUMATOLOGY. WILEY; 2017.